CR1 and the "vanishing amyloid" hypothesis of Alzheimer's disease.
作者信息
Gandy Sam, Haroutunian Vahram, DeKosky Steven T, Sano Mary, Schadt Eric E
机构信息
Department of Psychiatry and Alzheimer's Disease Research Center, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA.
出版信息
Biol Psychiatry. 2013 Mar 1;73(5):393-5. doi: 10.1016/j.biopsych.2013.01.013.
Abstract
摘要
相似文献
1
CR1 and the "vanishing amyloid" hypothesis of Alzheimer's disease.CR1与阿尔茨海默病的“淀粉样蛋白消失”假说
Biol Psychiatry. 2013 Mar 1;73(5):393-5. doi: 10.1016/j.biopsych.2013.01.013.
2
Effect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotype.补体 CR1 对衰老过程中脑淀粉样蛋白负担的影响及其受 APOE 基因型的修饰作用。
Biol Psychiatry. 2013 Mar 1;73(5):422-8. doi: 10.1016/j.biopsych.2012.08.015. Epub 2012 Sep 27.
3
Alzheimer's disease beyond APOE.载脂蛋白E之外的阿尔茨海默病
Nat Genet. 2009 Oct;41(10):1047-8. doi: 10.1038/ng1009-1047.
4
Genetics of Alzheimer's disease: new evidences for an old hypothesis?阿尔茨海默病的遗传学：旧假说的新证据？
Curr Opin Genet Dev. 2011 Jun;21(3):295-301. doi: 10.1016/j.gde.2011.02.002. Epub 2011 Mar 1.
5
Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: Polymorphisms, structure, and function of complement receptor 1.阿尔茨海默病中淀粉样β肽与外周补体的相互作用：补体受体 1 的多态性、结构和功能。
Alzheimers Dement. 2018 Nov;14(11):1438-1449. doi: 10.1016/j.jalz.2018.04.003. Epub 2018 May 21.
6
CR1 in Alzheimer's disease.阿尔茨海默病中的补体受体1（CR1）
Mol Neurobiol. 2015 Apr;51(2):753-65. doi: 10.1007/s12035-014-8723-8. Epub 2014 May 4.
7
Genetic variation at CR1 increases risk of cerebral amyloid angiopathy.CR1 上的遗传变异增加了脑淀粉样血管病的风险。
Neurology. 2012 Jan 31;78(5):334-41. doi: 10.1212/WNL.0b013e3182452b40. Epub 2012 Jan 18.
8
Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts.CR1基因变异对健康、轻度认知障碍和阿尔茨海默病队列中脑脊液及神经影像学生物标志物的影响。
Mol Neurobiol. 2017 Jan;54(1):551-562. doi: 10.1007/s12035-015-9638-8. Epub 2016 Jan 7.
9
CR1, ABCA7, and APOE genes affect the features of cognitive impairment in Alzheimer's disease.补体受体1（CR1）、三磷酸腺苷结合盒转运体A7（ABCA7）和载脂蛋白E（APOE）基因影响阿尔茨海默病认知障碍的特征。
J Neurol Sci. 2014 Apr 15;339(1-2):91-6. doi: 10.1016/j.jns.2014.01.029. Epub 2014 Jan 31.
10
APP, APOE, complement receptor 1, clusterin and PICALM and their involvement in the herpes simplex life cycle.APP、APOE、补体受体 1、载脂蛋白 E 及 clusterin 和 PICALM 及其在单纯疱疹病毒生命周期中的作用。
Neurosci Lett. 2010 Oct 11;483(2):96-100. doi: 10.1016/j.neulet.2010.07.066. Epub 2010 Jul 30.
引用本文的文献
1
The Alzheimer's disease-associated complement receptor 1 variant confers risk by impacting glial phagocytosis.与阿尔茨海默病相关的补体受体1变体通过影响胶质细胞吞噬作用而带来风险。
Alzheimers Dement. 2025 Jul;21(7):e70458. doi: 10.1002/alz.70458.
2
Complement receptor 1 is expressed on brain cells and in the human brain.补体受体 1 表达于脑细胞和人脑。
Glia. 2023 Jun;71(6):1522-1535. doi: 10.1002/glia.24355. Epub 2023 Feb 24.
3
Alzheimer mutant speeds APP transport.阿尔茨海默病突变加速 APP 转运。
J Exp Med. 2021 Jun 7;218(6). doi: 10.1084/jem.20210511. Epub 2021 May 14.
4
Complement Activation in the Central Nervous System: A Biophysical Model for Immune Dysregulation in the Disease State.中枢神经系统中的补体激活：疾病状态下免疫失调的生物物理模型。
Front Mol Neurosci. 2021 Mar 4;14:620090. doi: 10.3389/fnmol.2021.620090. eCollection 2021.
5
Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer's disease.CR1基因变异对阿尔茨海默病患者脑脊液及神经影像学生物标志物的影响
BMC Med Genet. 2020 Sep 12;21(1):181. doi: 10.1186/s12881-020-01114-x.
6
Complement receptor 1 genetic polymorphism contributes to sporadic Alzheimer's disease susceptibility in Caucasians: a meta-analysis.补体受体 1 基因多态性与散发性阿尔茨海默病易感性在白种人群中的相关性：一项荟萃分析。
Biosci Rep. 2020 Jun 26;40(6). doi: 10.1042/BSR20200321.
7
Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.载脂蛋白 E 和丁酰胆碱酯酶基因在前瞻性队列研究阿尔茨海默病风险中的相互作用。
J Alzheimers Dis. 2020;75(2):417-427. doi: 10.3233/JAD-191335.
8
Evaluation of the Common Molecular Basis in Alzheimer's and Parkinson's Diseases.评估阿尔茨海默病和帕金森病的常见分子基础。
Int J Mol Sci. 2019 Jul 30;20(15):3730. doi: 10.3390/ijms20153730.
9
Big Omics Data Experience.大型组学数据经验。
SC Conf Proc. 2015 Nov;2015. doi: 10.1145/2807591.2807595.
10
The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease.西奈山队列的大规模基因组、转录组和蛋白质组学数据在阿尔茨海默病中的应用。
Sci Data. 2018 Sep 11;5:180185. doi: 10.1038/sdata.2018.185.
本文引用的文献
1
Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress.针对阿尔茨海默病的治疗和预防：合理的策略和最新进展。
Annu Rev Med. 2013;64:367-83. doi: 10.1146/annurev-med-092611-084441.
2
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice.NLRP3 在阿尔茨海默病中被激活，并促进 APP/PS1 小鼠的病变。
Nature. 2013 Jan 31;493(7434):674-8. doi: 10.1038/nature11729. Epub 2012 Dec 19.
3
Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline.抑制白细胞介素 12/23 信号通路可减轻阿尔茨海默病样病理和认知功能减退。
Nat Med. 2012 Dec;18(12):1812-9. doi: 10.1038/nm.2965. Epub 2012 Nov 25.
4
Variant of TREM2 associated with the risk of Alzheimer's disease.与阿尔茨海默病风险相关的 Trem2 变异。
N Engl J Med. 2013 Jan 10;368(2):107-16. doi: 10.1056/NEJMoa1211103. Epub 2012 Nov 14.
5
Effect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotype.补体 CR1 对衰老过程中脑淀粉样蛋白负担的影响及其受 APOE 基因型的修饰作用。
Biol Psychiatry. 2013 Mar 1;73(5):422-8. doi: 10.1016/j.biopsych.2012.08.015. Epub 2012 Sep 27.
6
C-reactive protein and familial risk for dementia: a phenotype for successful cognitive aging.C 反应蛋白与痴呆家族风险：认知成功老化的表型。
Neurology. 2012 Sep 11;79(11):1116-23. doi: 10.1212/WNL.0b013e3182698c89. Epub 2012 Aug 15.
7
Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers.在存在淀粉样蛋白病理生物标志物的情况下，北极 APP 突变携带者的 PiB PET 保留率较低。
Neurology. 2012 Jul 17;79(3):229-36. doi: 10.1212/WNL.0b013e31825fdf18. Epub 2012 Jun 13.
8
Stitching together multiple data dimensions reveals interacting metabolomic and transcriptomic networks that modulate cell regulation.将多个数据维度拼接起来，揭示了相互作用的代谢组学和转录组学网络，这些网络调节细胞调控。
PLoS Biol. 2012;10(4):e1001301. doi: 10.1371/journal.pbio.1001301. Epub 2012 Apr 3.
9
Distinguishing between longevity and buffered-deleterious genotypes for exceptional human longevity: the case of the MTP gene.区分长寿和缓冲有害基因型以实现人类超长寿命：以 MTP 基因为例。
J Gerontol A Biol Sci Med Sci. 2012 Nov;67(11):1153-60. doi: 10.1093/gerona/gls103. Epub 2012 Apr 10.
10
A survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort.对病态肥胖队列的胃、肝和脂肪组织基因表达的遗传学调查。
Genome Res. 2011 Jul;21(7):1008-16. doi: 10.1101/gr.112821.110. Epub 2011 May 20.
Zotero 插件